Profile
FEMY ISRG BDX BDXA ALC RMD
Company Name Femasys Inc. Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $35.95M $176.09B $65.60B $64.58B $45.56B $33.16B
Employees 0.03K 15.64K 70.00K 0.00K 25.60K 9.98K
CEO Ms. Kathy Lee-Sepsick M.B.A. Dr. Gary S. Guthart Ph.D. Mr. Thomas E. Polen Jr. - Mr. David J. Endicott Mr. Michael J. Farrell BE, MBA, SM
Ratings
FEMY ISRG BDX BDXA ALC RMD
Quant Rating Score 1 3 3 5 3 3
Quant Rating Strong Sell Neutral Neutral Strong Buy Neutral Neutral
Trading
FEMY ISRG BDX BDXA ALC RMD
Last Close $1.46 $493.72 $224.92 $59.24 $89.15 $225.79
High 52 $2 $610.45 $249.08 $59.24 $100.76 $257.65
Low 52 $0.86 $366.34 $220.02 $59.24 $77.58 $173.83
Price vs. 52 Week High -27 % -19.12 % -9.7 % 0 % -11.52 % -12.37 %
Price vs. 52 Week Low 69.77 % 34.77 % 2.23 % 0 % 14.91 % 29.89 %
Total Return
FEMY ISRG BDX BDXA ALC RMD
1 Month Return 10.61 % -16.26 % -0.41 % 0 % 1.12 % -4.57 %
3 Month Return 22.69 % -8.5 % -0.28 % 0 % 5.92 % -5.34 %
6 Month Return 30.36 % -0.06 % -4.49 % 0 % -11.52 % -9.94 %
9 Month Return 40.38 % 15.33 % -3.88 % 0 % -3.37 % 7.07 %
YTD Return 32.73 % -5.41 % -0.86 % 0 % 5.02 % -1.27 %
1 Year Return -23.56 % 26.79 % -5.42 % 0 % 1.16 % 16.52 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
FEMY ISRG BDX BDXA ALC RMD
Dividend Yield Percentage (TTM) - - 1.7 % 1.73 % 0.29 % 0.92 %
Dividend Paid and Capex Coverage Ration (TTM) -23.21 % 2.17 % 1.98 % 1.98 % 2.05 % 3.84 %
Dividend Per Share (TTM) - - 3.89 % 3.89 % 0.26 % 2.07 %
Payout Ratio (TTM) - - 65.26 % 65.26 % 13.01 % 23.76 %
Profitability
FEMY ISRG BDX BDXA ALC RMD
Gross Profit Margin TTM 28.86 % 67.46 % 45.22 % 45.22 % 55.61 % 57.94 %
Return on Assets TTM -116.16 % 12.39 % 3.16 % 3.16 % 3.35 % 17.49 %
Return on Equity TTM -141.49 % 15.31 % 6.73 % 6.73 % 6.43 % 25.05 %
Return on Capital Employed TTM -137.7 % 13.82 % 5.64 % 5.64 % 5.03 % 24.81 %
Net Income Per EBT TTM 100.02 % 86.87 % 88.43 % 88.43 % 81.05 % 81.35 %
EBT Per Ebit TTM 103.35 % 113.83 % 73.61 % 73.61 % 88.89 % 98.37 %
EBIT Per Revenue TTM -1389.19 % 28.12 % 12.85 % 12.85 % 14.24 % 31.67 %
Cash Flow To Debt Ratio TTM -240.49 % - 19.46 % 19.46 % 36.06 % 175.81 %
Receivables Turnover TTM 3.33 6.16 7.82 7.82 4.77 5.73
Payables Turnover TTM 0.8 14.05 - - 5.7 9.41
Inventory Turnover TTM 0.46 1.83 2.93 2.93 1.94 2.35
Fixed Asset Turnover TTM 37.86 % 179.75 % 312.63 % 312.63 % 205.17 % 734.05 %
Asset Turnover TTM 8.09 % 44.56 % 37.76 % 37.76 % 32.71 % 68.99 %
Operating Cash Flow Per Share TTM -0.78 6.78 12.61 12.61 3.75 10.05
Free Cash Flow Per Share TTM -0.81 3.66 10.14 10.14 2.19 9.45
Cash Per Share TTM 34.23 % 1126.07 % 251.46 % 251.46 % 370.15 % 355.4 %
Operating Cash Flow Sales Ratio TTM -1380.68 % 28.91 % 17.68 % 17.68 % 18.66 % 29.96 %
Free Cash Flow Operating Cash Flow Ratio TTM 104.02 % 53.99 % 80.44 % 80.44 % 58.38 % 94.04 %
Cash Flow Coverage Ratios TTM -240.49 % - 19.46 % 19.46 % 36.06 % 175.81 %
Price To Free Cash Flows Ratio TTM -1.99 135.06 22.34 22.04 42.14 23.88
Price To Operating Cash Flows Ratio TTM -2.01 72.86 18.12 17.87 24.59 22.46
Price Cash Flow Ratio TTM -2.01 72.86 18.12 17.87 24.59 22.46
Income Statement (TTM)
FEMY ISRG BDX BDXA ALC RMD
Revenue $0B $8.35B $20.18B $20.18B $9.91B $4.69B
Gross Profit $0B $5.63B $9.13B $9.13B $5.51B $2.66B
Gross Profit Ratio 64.54% 67.5% 45.22% 45.22% 55.61% 56.67%
EBITDA $-0.01B $2.67B $4.85B $4.85B $2.68B $1.53B
Net Income $-0.01B $2.32B $1.71B $1.71B $1.02B $1.02B
EPS Diluted -0.93 6.42 5.86 5.86 2.05 6.92
Balance Sheet (MRQ)
FEMY ISRG BDX BDXA ALC RMD
Long Term Debt $0.01B $0B $17.94B $17.94B $4.97B $0.84B
Total Liabilities $0.01B $2.21B $31.4B $31.4B $8.79B $2.01B
Total Equity $0.02B $16.53B $25.91B $25.91B $21.55B $4.86B
Total Investments $0B $6.81B $0.45B $0.45B $0.75B $0.17B
Total Debt $0.01B $0B $20.11B $20.11B $5.14B $0.87B
Total Assets $0.03B $18.74B $57.29B $57.29B $30.35B $6.87B
Cash Flow Statement (TTM)
FEMY ISRG BDX BDXA ALC RMD
Net Income $-0.01B $2.34B $1.71B $1.71B $1.02B $1.02B
Inventory $-0B $-0.83B $0.1B $0.1B $-0.05B $0.17B
Dividends Paid $0B $0B $-1.1B $-1.1B $-0.13B $-0.28B
Operating Cash Flow $-0.01B $2.42B $3.84B $3.84B $2.08B $1.4B
Capital Expenditure $-0B $-1.11B $-0.73B $-0.73B $-0.67B $-0.11B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.62
ALC Alcon Inc. 89.22
ANGO AngioDynamics, Inc. 9.05
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 147.715
ATRC AtriCure, Inc. 33.39
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AZTA Azenta, Inc. 38.79
BAX Baxter International Inc. 35.08
BDX Becton, Dickinson and Company 225.97
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 15.405
BLFS BioLife Solutions, Inc. 26.41
COO The Cooper Companies, Inc. 80.51
DXR Daxor Corporation 7.9
EKSO Ekso Bionics Holdings, Inc. 0.3891
GCTK GlucoTrack, Inc. 0.3564
ETFs With Exposure to FEMY
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 274.99
VXF Vanguard Extended Market Index Fund 0 173.535
DFAS Dimensional U.S. Small Cap ETF 0.00006446 59.73
VTSAX Vanguard Total Stock Market Index Fund 0 133.29
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 131.19
VITSX Vanguard Total Stock Market Index Fund 0 133.31
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 131.2
VEMPX Vanguard Extended Market Index InstlPlus 0 323.75
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 250.07
Unlock